Literature DB >> 33895359

HepQuant SHUNT Detects Portal Hypertension in Early Stages of Clinically Compensated Chronic Liver Disease.

Amanda Wieland1, Ohad Etzion2, Rabab O Ali2, Elliot Levy2, David E Kleiner3, Steve M Helmke4, Theo Heller2, Gregory T Everson5.   

Abstract

Physicians use portal pressure measurements in clinical practice and research but the methods are invasive, can cause complications, and are resource intensive.1-3 Herein we describe preliminary findings of the minimally invasive HepQuant-SHUNT test in the diagnosis of portal hypertension in precirrhotic and compensated cirrhotic patients.
Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2021        PMID： 33895359      PMCID： PMC8531144          DOI： 10.1016/j.cgh.2021.04.030

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


  8 in total

Review 1.  Portal hypertension and its complications.

Authors:  Arun J Sanyal; Jaime Bosch; Andres Blei; Vincente Arroyo
Journal:  Gastroenterology       Date:  2008-05       Impact factor: 22.682

2.  The within-individual reproducibility of the disease severity index from the HepQuant SHUNT test of liver function and physiology.

Authors:  James R Burton; Steven Helmke; Shannon Lauriski; John Kittelson; Gregory T Everson
Journal:  Transl Res       Date:  2021-01-02       Impact factor: 7.012

3.  Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis.

Authors:  A Perelló; A Escorsell; C Bru; R Gilabert; E Moitinho; J C García-Pagán; J Bosch
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

Review 4.  The noninvasive diagnosis of esophageal varices and its application in clinical practice.

Authors:  Etienne Pateu; Frédéric Oberti; Paul Calès
Journal:  Clin Res Hepatol Gastroenterol       Date:  2017-09-01       Impact factor: 2.947

5.  Portal hypertension in primary biliary cholangitis: prevalence, natural history and histological correlates.

Authors:  Thomas W Warnes; Stephen A Roberts; Alexander Smith; Victor M Cope; Patricia Vales; Najib Y Haboubi; Raymond F McMahon
Journal:  Eur J Gastroenterol Hepatol       Date:  2020-12-14       Impact factor: 2.566

6.  Predicting clinical decompensation in patients with cirrhosis using the Hepquant-SHUNT test.

Authors:  Mohammad Amin Fallahzadeh; Daniel J Hansen; James F Trotter; Gregory T Everson; Giovanna Saracino; Robert S Rahimi; Steve Helmke; Jodi Boutte; Sumeet K Asrani
Journal:  Aliment Pharmacol Ther       Date:  2021-02-08       Impact factor: 8.171

7.  Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension.

Authors:  N Afdhal; G T Everson; J L Calleja; G W McCaughan; J Bosch; D M Brainard; J G McHutchison; S De-Oertel; D An; M Charlton; K R Reddy; T Asselah; E Gane; M P Curry; X Forns
Journal:  J Viral Hepat       Date:  2017-04-10       Impact factor: 3.728

Review 8.  Noninvasive assessment of liver function.

Authors:  Steve Helmke; Jordi Colmenero; Gregory T Everson
Journal:  Curr Opin Gastroenterol       Date:  2015-05       Impact factor: 3.287
  8 in total
  1 in total

Review 1.  Bibliometric-analysis visualization and review of non-invasive methods for monitoring and managing the portal hypertension.

Authors:  XiaoHan Sun; Hong Bo Ni; Jian Xue; Shuai Wang; Afaf Aljbri; Liuchun Wang; Tian Hang Ren; Xiao Li; Meng Niu
Journal:  Front Med (Lausanne)       Date:  2022-09-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.